Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,080,916
-$43,376 QoQ
Shares Held
23,976
-7.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#1,321
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SMITH, MOORE & CO. holds $27,430,178 across 9 Drug Manufacturers - General names. MRK ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
28,543 | $7,182,560 | |
| 2 | LLY |
ELI LILLY & Co
|
5,912 | $7,091,030 | |
| 3 | JNJ |
Johnson & Johnson
|
23,180 | $5,887,024 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
23,976 | $3,080,916 | |
| 5 | AMGN |
Amgen Inc
|
4,729 | $1,712,465 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,730 | $906,362 | |
| 7 | PFE |
Pfizer Inc
|
32,201 | $775,400 | |
| 8 | AZN |
Astrazeneca PLC
|
2,644 | $501,355 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,080,916 | 23,976 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,124,292 | 25,973 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $3,214,535 | 30,539 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,981,923 | 23,614 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,816,801 | 22,951 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,019,510 | 22,499 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,250,436 | 22,622 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,513,877 | 22,137 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,617,255 | 21,141 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,606,276 | 19,752 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,169,388 | 19,899 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,059,823 | 20,008 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,329,147 | 20,185 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,054,497 | 19,311 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,230,316 | 20,102 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,668,402 | 19,373 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,770,247 | 19,417 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,381,639 | 16,839 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,249,845 | 16,308 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,149,183 | 15,300 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,101,223 | 14,160 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $972,259 | 12,612 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $799,022 | 9,768 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,094,111 | 13,190 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $885,970 | 11,457 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $892,888 | 11,605 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||